Wearable-Derived Training Load and Coronary Atherosclerosis in Middle-Aged and Older Athletes and Physically Active Controls: A New Perspective From the Master@Heart Study

R Rik Pauwels (Department of Cardiology, Hartcentrum (R.P., J.D.P., Y.B., B.D., L.H., G.C.), Jessa Ziekenhuis, Hasselt, Belgium.) C Christophe Dausin (Department of Movement Sciences (C.D.), Katholieke Universiteit Leuven, Belgium.) S Sergio Ruiz-Carmona (Department of Cardiology (S.R.-C.), Baker Heart and Diabetes Institute, Melbourne, Australia.) R Ruben De Bosscher (Department of Cardiovascular Sciences (R.P., R.D.B., J.D.P., Y.B., B.D., P.S., T.K., T.R., R.W., G.C.), Katholieke Universiteit Leuven, Belgium.) J Jarne De Paepe (Department of Cardiology, Hartcentrum (R.P., J.D.P., Y.B., B.D., L.H., G.C.), Jessa Ziekenhuis, Hasselt, Belgium.) Y Youri Bekhuis B Boris Delpire (Department of Cardiology, Hartcentrum (R.P., J.D.P., Y.B., B.D., L.H., G.C.), Jessa Ziekenhuis, Hasselt, Belgium.) P Peter Sinnaeve (Department of Cardiology, Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Belgium (P.S.).) S Steven Dymarkowski (Department of Radiology (S.D.), University Hospitals Leuven, Belgium.) O Olivier Ghekiere (Department of Radiology (O.G.), Jessa Ziekenhuis, Hasselt, Belgium.) L Liesbeth Bruckers (I-Biostat, Data Science Institute, Hasselt University, Belgium (L.B.).) T Tatiana Kuznetsova C Caroline M. Van De Heyning (Department of Cardiovascular Sciences, University of Antwerp, Belgium (C.M.V.D.H., P.L.V.H., H.H.).) P Paul L. Van Herck (Department of Cardiovascular Sciences, University of Antwerp, Belgium (C.M.V.D.H., P.L.V.H., H.H.).) T Thijs M.H. Eijsvogels (Department of Medical BioSciences, Exercise Physiology Research Group, Radboud University Medical Center, Nijmegen, The Netherlands (T.M.H.E.).) L Lieven Herbots (Faculty of Medicine and Life Sciences, Limburg Clinical Research Center, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium (S.D., S.M.F., P.K., E.M., K.T., S.D., L.H., W.M., J.V., P.B.B.).) T Tomas Robyns (Department of Cardiovascular Sciences (R.P., R.D.B., J.D.P., Y.B., B.D., P.S., T.K., T.R., R.W., G.C.), Katholieke Universiteit Leuven, Belgium.) A André La Gerche (Heart, Exercise and Research Trials Laboratory, Saint Vincent’s Institute of Medical Research, Melbourne, Australia (A.L.G.).) H Hein Heidbüchel (University Hospital Antwerp, Antwerp, Belgium) R Rik Willems (Department of Cardiovascular Sciences (R.P., R.D.B., J.D.P., Y.B., B.D., P.S., T.K., T.R., R.W., G.C.), Katholieke Universiteit Leuven, Belgium.) G Guido Claessen J Jan Bogaert K Kaatje Goetschalckx P Piet Claus D Diane Fatkin S Sofie Van Soest K Kristel Janssens M Mathias Claeys P Peter Hespel T Tom Dresselaers H Hielko Miljoen K Kasper Favere B Bernard Paelinck D Dorien Vermeulen I Isabel Witvrouwen D Dominique Hansen B Bert Op’t Eijnde D Daisy Thijs P Peter Vanvoorden K Kristof Lefebvre P Paolo D’Ambrosio S Stephanie Rowe A Amy M. Mitchell L Luke Spencer J Jürgen Duchenne

Abstract

BACKGROUND: Middle-aged and older endurance athletes have increased prevalence of coronary artery disease (CAD) on coronary computed tomography angiography compared with healthy controls, despite similarly low cardiovascular risk. Previous studies relied on self-reported data to quantify training load (TL), which poorly correlates with objective wearable-derived TL and may bias outcomes. The effect of objective TL on CAD risk remains unknown. METHODS: In this observational, cross-sectional analysis of the Master@Heart study, 222 men (median age, 54 [49–59] years) were included: 77 lifelong athletes, 98 late-onset athletes, and 47 controls. TL was assessed using objective wearable-derived training duration and intensity (12 consecutive months), as well as self-reported training measures. Coronary computed tomography angiography–derived CAD prevalence was compared across TL quartiles (Q) using a global unadjusted chi-square test and logistic regression, adjusted for cardiovascular risk factors and years of endurance exercise, to estimate odds ratios between Q4 and Q1. In addition, adjusted logistic regression models were fitted with continuous TL, using smoothing splines to capture potential nonlinear associations. RESULTS: Across quartiles of objective Edwards training impulse (training duration × heart rate–weighted intensity), unadjusted global differences were observed for ≥1 plaque ( P <0.001), coronary artery calcification (CAC)>0 ( P =0.002), and CAC>100 ( P =0.012). Q4 participants had significantly higher adjusted odds of ≥1 plaque (odds ratio, 5.85; 95% CI, 2.33–14.71), CAC>0 (odds ratio, 5.03; 95% CI, 2.04–12.35), and CAC>100 (odds ratio, 3.50; 95% CI, 1.22–10.00) versus Q1. Similar associations were found for objective training duration, whereas no clear associations were observed for relative time spent in high-intensity zones. In continuous analyses, Edwards training impulse and objective training duration showed significant positive associations with ≥1 plaque and CAC>100 ( P <0.05), whereas self-reported training duration was only significantly associated with CAC>100 ( P <0.05). Metabolic equivalent of task-minutes per week based on self-reported TL was not associated with CAD ( P >0.05). CONCLUSIONS: High training duration (hours/week), particularly when combined with cumulative high-intensity TL (Edwards training impulse), was independently associated with increased prevalence of subclinical CAD in middle-aged and older athletes and physically active controls. Exercise intensity alone, in the absence of high duration, was not clearly linked to CAD. These findings underscore the potential of objectively measured TL for understanding associations with subclinical CAD in endurance athletes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03711539.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue 14
Published April 07, 2026
Pages 1009-1022
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (45)

R

Rik Pauwels

Department of Cardiology, Hartcentrum (R.P., J.D.P., Y.B., B.D., L.H., G.C.), Jessa Ziekenhuis, Hasselt, Belgium.

C

Christophe Dausin

Department of Movement Sciences (C.D.), Katholieke Universiteit Leuven, Belgium.

S

Sergio Ruiz-Carmona

Department of Cardiology (S.R.-C.), Baker Heart and Diabetes Institute, Melbourne, Australia.

R

Ruben De Bosscher

Department of Cardiovascular Sciences (R.P., R.D.B., J.D.P., Y.B., B.D., P.S., T.K., T.R., R.W., G.C.), Katholieke Universiteit Leuven, Belgium.

J

Jarne De Paepe

Department of Cardiology, Hartcentrum (R.P., J.D.P., Y.B., B.D., L.H., G.C.), Jessa Ziekenhuis, Hasselt, Belgium.

Y

Youri Bekhuis

B

Boris Delpire

Department of Cardiology, Hartcentrum (R.P., J.D.P., Y.B., B.D., L.H., G.C.), Jessa Ziekenhuis, Hasselt, Belgium.

P

Peter Sinnaeve

Department of Cardiology, Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Belgium (P.S.).

S

Steven Dymarkowski

Department of Radiology (S.D.), University Hospitals Leuven, Belgium.

O

Olivier Ghekiere

Department of Radiology (O.G.), Jessa Ziekenhuis, Hasselt, Belgium.

L

Liesbeth Bruckers

I-Biostat, Data Science Institute, Hasselt University, Belgium (L.B.).

T

Tatiana Kuznetsova

C

Caroline M. Van De Heyning

Department of Cardiovascular Sciences, University of Antwerp, Belgium (C.M.V.D.H., P.L.V.H., H.H.).

P

Paul L. Van Herck

Department of Cardiovascular Sciences, University of Antwerp, Belgium (C.M.V.D.H., P.L.V.H., H.H.).

T

Thijs M.H. Eijsvogels

Department of Medical BioSciences, Exercise Physiology Research Group, Radboud University Medical Center, Nijmegen, The Netherlands (T.M.H.E.).

L

Lieven Herbots

Faculty of Medicine and Life Sciences, Limburg Clinical Research Center, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium (S.D., S.M.F., P.K., E.M., K.T., S.D., L.H., W.M., J.V., P.B.B.).

T

Tomas Robyns

Department of Cardiovascular Sciences (R.P., R.D.B., J.D.P., Y.B., B.D., P.S., T.K., T.R., R.W., G.C.), Katholieke Universiteit Leuven, Belgium.

A

André La Gerche

Heart, Exercise and Research Trials Laboratory, Saint Vincent’s Institute of Medical Research, Melbourne, Australia (A.L.G.).

H

Hein Heidbüchel

University Hospital Antwerp, Antwerp, Belgium

R

Rik Willems

Department of Cardiovascular Sciences (R.P., R.D.B., J.D.P., Y.B., B.D., P.S., T.K., T.R., R.W., G.C.), Katholieke Universiteit Leuven, Belgium.

G

Guido Claessen

J

Jan Bogaert

K

Kaatje Goetschalckx

P

Piet Claus

D

Diane Fatkin

S

Sofie Van Soest

K

Kristel Janssens

M

Mathias Claeys

P

Peter Hespel

T

Tom Dresselaers

H

Hielko Miljoen

K

Kasper Favere

B

Bernard Paelinck

D

Dorien Vermeulen

I

Isabel Witvrouwen

D

Dominique Hansen

B

Bert Op’t Eijnde

D

Daisy Thijs

P

Peter Vanvoorden

K

Kristof Lefebvre

P

Paolo D’Ambrosio

S

Stephanie Rowe

A

Amy M. Mitchell

L

Luke Spencer

J

Jürgen Duchenne